A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

Peng Cao,Ji-Yue Wu,Jian-Dong Zhang,Ze-Jia Sun,Xiang Zheng,Bao-Zhong Yu,Hao-Yuan Cao,Fei-Long Zhang,Zi-Hao Gao,Wei Wang
DOI: https://doi.org/10.1186/s12885-022-09755-2
IF: 4.638
2022-06-24
BMC Cancer
Abstract:Renal cell carcinoma (RCC) is a third most common tumor of the urinary system. Nowadays, Immunotherapy is a hot topic in the treatment of solid tumors, especially for those tumors with pre-activated immune state.
oncology
What problem does this paper attempt to address?